IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James Perry who wrote (359)	2/13/1997 1:09:00 AM
From: I. Luttichuys	of 1762

James, I am not sure why no 10-K is in EDGAR. But do agree about the fundamentals I have seen. They seem to be serious about controlling costs especially. I might add that I have discussed this stock with a biochemistry PhD here, very knowledgable in this company, who has a sizable holding. His opinions were quite enlightening and bullish. Remember that this is/was a research company which is about to bring to products to commercial status and, I think, this will change the market's ideas and valuations of this stock inherently. In addition, if you noticed, MABXA's agreements with Roche and Abbott should give them an infrastructure already in place to capture up to 50% of the world market for their tests. It is most interesting. Today's newswire report on IDEC's acquisition IMO puts a whole new spin on the IDEC story potentially. I think that the more you shake this thing, the more result we will see when the lid comes off. I might also add that I think I may have fallen in love with IDEC but so far find the relationship quite comfortable for the time being :o). BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next